Managed-Care Organizations In Clinical Trials
RAY OF HOPE: Cancer-prevention specialist Jon Kerner says MCOs support Phase III trials in some cases.
MCOs claim that clinical-trial expenses are not part of their responsibility to provide cost-effective care. But some people affiliated with MCOs point out that under the right circumstances, their organizations will participate in...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?